TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/24 17:05 | 5/3/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | M.d | 836 | 4.18 | 0 | 200 | 10 | 2,293 | D | ||||||||||||||
4/1/24 17:20 | 3/31/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | M.d | 0 | 0.00 | 0 | 11 | 1 | 2,093 | D | ||||||||||||||
3/16/23 17:24 | 3/14/23 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | P.m | 2,449 | 26.32 | 0 | 93 | 5 | 2,049 | D | ||||||||||||||
11/23/21 19:07 | 11/19/21 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | P.m | 10,048 | 96.15 | 0 | 105 | 5 | 2,322 | D | ||||||||||||||
8/17/21 19:02 | 8/13/21 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | M.d | 100 | 4.18 | 0 | 24 | 1 | 2,217 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |